169 related articles for article (PubMed ID: 10190084)
61. Intermittent three-month treatment with Ukrain in intact and ovariectomized rats. Part II: Effect on bone mineral density of the femur.
Jabłoński M; Gorzelak M; Patyra M; Jagiełło-Wójtowicz E
Drugs Exp Clin Res; 2000; 26(5-6):327-31. PubMed ID: 11345047
[TBL] [Abstract][Full Text] [Related]
62. Ukrain therapy of stage T1N0M0 bladder cancer patients.
Uglianitsa KN; Nechiporenko NA; Nefyodov LI; Brzosko WJ
Drugs Exp Clin Res; 1998; 24(5-6):227-30. PubMed ID: 10190079
[TBL] [Abstract][Full Text] [Related]
63. Selective inhibition of in vitro cell growth by the anti-tumour drug Ukrain.
Hohenwarter O; Strutzenberger K; Katinger H; Liepins A; Nowicky JW
Drugs Exp Clin Res; 1992; 18 Suppl():1-4. PubMed ID: 1305034
[TBL] [Abstract][Full Text] [Related]
64. Effect of six-month treatment with Ukrain on early osteoporosis induced by ovariectomy in rats. Part II: Preliminary studies of peripheral blood parameters.
Jagiełło-Wojtowicz E; Kleinrok Z; Nowicky JW; Chodkowska A; Feldo M; Surmaczynska B; Gorzelak M; Jablonski M
Drugs Exp Clin Res; 1996; 22(3-5):177-80. PubMed ID: 8899325
[TBL] [Abstract][Full Text] [Related]
65. Preliminary pharmacokinetic studies of Ukrain in rats.
Jagiello-Wójtowicz E; Kleinrok Z; Chodkowska A; Misztal G; Jagiello G
Drugs Exp Clin Res; 1998; 24(5-6):309-11. PubMed ID: 10190093
[TBL] [Abstract][Full Text] [Related]
66. [The immunoregulatory properties of recombinant human tumor necrosis factor-beta in mice opposite-reacting to antigen].
Masycheva VI; Fadina VA; Danilenko ED; Sysoeva GM; Ratner GM; Stakheeva MN; Stepovaia EA; Khlusova MIu; Sherstoboev EIu; Pustoshilova NM
Eksp Klin Farmakol; 1999; 62(4):44-7. PubMed ID: 10513336
[TBL] [Abstract][Full Text] [Related]
67. [The characteristics of the action of the immunomodulator MOP-35 on macrophage 5'-nucleotidase activity depending on the time of day].
Kirillicheva GB; Baturina IG; Mit'kin VV; Goncharov NP; Smirnova GP; Ignatenko MA; Sukhikh GT
Biull Eksp Biol Med; 1992 Nov; 114(11):525-7. PubMed ID: 1290832
[No Abstract] [Full Text] [Related]
68. Macrophages play a critical role in the anti-tumor activity of Virulizin.
Du C; Feng N; Jin H; Lee V; Wang M; Wright JA; Young AH
Int J Oncol; 2003 Nov; 23(5):1341-6. PubMed ID: 14532975
[TBL] [Abstract][Full Text] [Related]
69. Activation of spleen cell lytic activity by the alkaloid thiophosphoric acid derivative: Ukrain.
Liepins A; Nowicky JW
Int J Immunopharmacol; 1992 Nov; 14(8):1437-42. PubMed ID: 1464476
[TBL] [Abstract][Full Text] [Related]
70. Ukrain (NSC-631570) in the treatment of pancreas cancer.
Zemskov VS; Procopchuk OL; Susak YM; Zemskov SV; Hodysh YY; Zemskova MV
Drugs Exp Clin Res; 2000; 26(5-6):179-90. PubMed ID: 11345025
[TBL] [Abstract][Full Text] [Related]
71. Biological activity of some thiophosphamide derivatives of alkaloids with respect to influenza virus.
Lisnyak OI; Lozjuk RM
Drugs Exp Clin Res; 1996; 22(3-5):225-8. PubMed ID: 8899336
[TBL] [Abstract][Full Text] [Related]
72. Amino acids and their derivatives in tumour tissue from patients with breast cancer treated with Ukrain. Part VI.
Nefyodov LI; Uglyanica KN; Smirnov VY; Doroshenko YM; Fomin KA; Nowicky JW; Brzosko WJ
Drugs Exp Clin Res; 1996; 22(3-5):159-61. PubMed ID: 8899321
[TBL] [Abstract][Full Text] [Related]
73. Evaluation of the efficacy of Ukrain in the treatment of breast cancer: clinical and laboratory studies.
Uglianitsa KN; Nefyodov LI; Brzosko W
Drugs Exp Clin Res; 1998; 24(5-6):231-9. PubMed ID: 10190080
[TBL] [Abstract][Full Text] [Related]
74. New biochemical mechanisms of the anticancer effect of Ukrain in the treatment of cancer of the urinary bladder.
Nefyodov LI; Uglyanitsa KN; Nechiporenko NA; Smirnov VY; Brzosko W; Karavay NL
Drugs Exp Clin Res; 2000; 26(5-6):195-9. PubMed ID: 11345027
[TBL] [Abstract][Full Text] [Related]
75. Ukrain, a plant derived semi-synthetic compound, exerts antitumor effects against murine and human breast cancer and induce protective antitumor immunity in mice.
Bozeman EN; Srivatsan S; Mohammadi H; Daniels D; Shashidharamurthy R; Selvaraj P
Exp Oncol; 2012 Dec; 34(4):340-7. PubMed ID: 23302993
[TBL] [Abstract][Full Text] [Related]
76. Pharmacological effects of Ukrain in rats and rabbits.
Remiszewska M; Wutkiewicz M; Jastrzebski Z; Czyzewska-Szafran H; Danysz A
Acta Pol Pharm; 1992; 49(4):43-5. PubMed ID: 16092434
[TBL] [Abstract][Full Text] [Related]
77. Influence of Ukrain on immunological blood parameters in vitro and in vivo.
Nowicky JW; Hiesmayr W; Liepins A
Drugs Exp Clin Res; 1996; 22(3-5):163-5. PubMed ID: 8899322
[TBL] [Abstract][Full Text] [Related]
78. A method for determination of Ukrain in blood plasma for monitoring and pharmacokinetic study.
Doroshenko YM; Hodysh YY; Uglyanitsa KN; Nefyodov LI
Drugs Exp Clin Res; 2000; 26(5-6):163-70. PubMed ID: 11345023
[TBL] [Abstract][Full Text] [Related]
79. Ukrain treatment in a patient with stage IV neuroblastoma. A case report.
Aschhoff B
Drugs Exp Clin Res; 1998; 24(5-6):243-5. PubMed ID: 10190082
[TBL] [Abstract][Full Text] [Related]
80. Antitumor effects of a new polysaccharide-protein complex (ATOM) prepared from Agaricus blazei (Iwade strain 101) "Himematsutake" and its mechanisms in tumor-bearing mice.
Ito H; Shimura K; Itoh H; Kawade M
Anticancer Res; 1997; 17(1A):277-84. PubMed ID: 9066665
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
